Complementary and alternative medicine (CAM) use in advanced cancer: A systematic review

Journal of Supportive Oncology

Volumn 11, Issue 3, 2013, Pages 105-113

  Truant, Tracy L ^a   Porcino, Antony J ^a   Ross, Brenda C ^b   Wong, Margurite E ^b,c   Hilario, Carla T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AGE DISTRIBUTION; ALTERNATIVE MEDICINE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DISEASE DURATION; EDUCATIONAL STATUS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MEDICAL DECISION MAKING; PATIENT SATISFACTION; PHASE 1 CLINICAL TRIAL (TOPIC); PREVALENCE; QUALITY OF LIFE; RELIGION; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; HEALTH CARE PERSONNEL; INTERPERSONAL COMMUNICATION; METHODOLOGY; NEOPLASM;

COMMUNICATION; COMPLEMENTARY THERAPIES; HEALTH PERSONNEL; HUMANS; NEOPLASMS;

EID: 84893183515     PISSN: 15446794     EISSN: 1879596X     Source Type: Journal    
DOI: 10.12788/j.suponc.0011     Document Type: Review

References (96)

1. Balboni TA, Vanderwerker LC, Block SD, et al. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol. 2007;25(5):555-560.
2. Can G, Erol O, Aydiner A, Topuz E. Quality of life and complementary and alternative medicine use among cancer patients in Turkey. Eur J Oncol Nurs. 2009;13(4):287-294.
3. Corbin LW, Mellis BK, Beaty BL, Kutner JS. The use of complementary and alternative medicine therapies by patients with advanced cancer and pain in a hospice setting: a multicentered, descriptive study. J Palliat Med. 2009;12(1):7-8.
4. Correa-Velez I, Clavarino A, Barnett AG, Eastwood H. Use of complementary and alternative medicine and quality of life: changes at the end of life. Palliat Med. 2003;17(8):695-703.
5. Correa-Velez I, Clavarino A, Eastwood H. Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med. 2005;8(5):953-961.
6. Dy GK, Bekele L, Hanson LJ, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials-[published correction appears in J Clin Oncol. 2005;23(1):248]. J Clin Oncol. 2004;22(23):4810-4815.
7. Eliott JA, Kealey CP, Olver IN. (Using) complementary and alternative medicine: the perceptions of palliative patients with cancer. J Palliat Med. 2008;11(1):58-67.
8. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998;83(4):777-782.
9. Gross AM, Liu Q, Bauer-Wu S. Prevalence and predictors of complementary therapy use in advanced stage breast cancer patients. J Onc Practice. 2007;3(6):292-295.
10. Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: A study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007;25(5):548-554.
11. Jordan ML, Delunas LR. Quality of life and patterns of nontraditional therapy use by patients with cancer. Oncol Nurs Forum. 2001;28(7):1107-1113.
12. Kav S, Pinar G, Gullu F, et al. Use of complementary and alternative medicine in patients with gynecologic cancer: is this usage more prevalent? J Altern Complement Med. 2008;14(4):347-349.
13. Klafke N, Eliott JA, Wittert GA, Olver IN. Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Ann Onc. 2012;23(6):1571-1578.
14. Kremser T, Evans A, Moore A, et al. Use of complementary therapies by Australian women with breast cancer. Breast. 2008;17(4):387-394.
15. Lafferty WE, Bellas A, Baden AC, Tyree PT, Standish LJ, Patterson R. The use of complementary and alternative medical providers by insured cancer patients in Washington State. Cancer. 2004;100(7):1522-1530.
16. Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK. Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care. 2008;14(5):326-334.
17. Maggiore RJ, Gross CP, Togawa K, et al. Use of complementary medications among older adults with cancer. Cancer. 2012;118(19):4815-4823.
18. Naing A, Stephen SK, Frenkel M, et al. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Cancer. 2011;117(22):5142-5150.
19. Oneschuk D, Fennell L, Hanson J, Bruera E. The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. J Palliat Care. 1998;14(4):21-26.
20. Oneschuk D, Hanson J, Bruera E. Complementary therapy use: a survey of community- and hospital-based patients with advanced cancer. Palliat Med. 2000;14(5):432-434.
21. Paltiel O, Avitzour M, Peretz T, et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol. 2001;19(9):2439-2448.
22. Ponholzer A, Struhal G, Madersbacher S. Frequent use of complementary medicine by prostate cancer patients. Eur Urol. 2003;43(6):604-608.
23. Risberg T, Lund E, Wist E, et al. The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. Eur J Cancer. 1995;31(11):1785-1789.
24. Risberg T, Lund E, Wist E. Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol. 1995;34(7):893-898.
25. Risberg T, Vickers A, Bremnes RM, Wist EA, Kaasa S, Cassileth BR. Does the use of alternative medicine predict survival from cancer? Eur J Cancer. 2003;39(3):372-377.
26. Shen J, Andersen R, Albert PS, et al. Use of complementary/ alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med. 2002;13;2:8.
27. Söllner W, Zingg-Schir M, Rumpold G, Fritsh P. Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol. 1997;133(3):316-321.
28. Tarhan O, Alacacioglu A, Somali I, et al. Complementaryalternative medicine among cancer patients in the western region of Turkey. J BUON. 2009;14(2):265-269.
29. Trinkaus M, Burman D, Barmala N, et al. Spirituality and use of complementary therapies for cure in advanced cancer. Psychooncology. 2011;20(7):746-754.
30. Yates PM, Beadle G, Clavarino A, et al. Patients with terminal cancer who use alternative therapies: their beliefs and practices. Sociol Health Ill. 1993;15(2):199-216.
31. Yildirim Y. Patterns of the use of complementary and alternative medicine in women with metastatic cancer. Cancer Nurs. 2010;33(3):194-200.
32. Engdal SS, Steinsbekk AA, Klepp OO, Nilsen OG. Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer. 2008;16(7):763-769.
33. Verhoef M. Complementary and alternative approaches in palliative care: why are advanced cancer patients using them? Prog Palliat Care. 2012;20(5):264-271.
34. Bishop FL, Rea A, Lewith H, et al. Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies. Prostate Cancer Prostatic Dis. 2011;14(1):1-13.
35. Boon H, Brown JB, Gavin A, Kennard MA, Stewart M. Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res. 1999;9(5):639-653.
36. Boon H, Stewart M, Kennard MA, et al. Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000;18(13):2515-2521.
37. Boon H, Brown JB, Gavin A. What are the experiences of women with breast cancer as they decide whether to use complementary/ alternative medicine. West J Med. 2000;173(1):39.
38. Boon H, Brown JB, Gavin A, Westlake K. Men with prostate cancer: making decisions about complementary/alternative medicine. Med Decis Making. 2003;23(6):471-479.
39. Boon H, Westlake K, Deber R, Moineddin R. Problem-solving and decision-making preferences: No difference between complementary and alternative medicine users and non-users. Complement Ther Med. 2005;13(3):213-216.
40. Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7:4.
41. DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002;20(18 Suppl.):34S-38S.
42. Ernst E, Hung SK. Great expectations: what do patients using complementary and alternative medicine hope for? Patient. 2011;4(2):89-101.
43. Fouladbakhsh JM, Stommel M, Given BA, Given CW. Predictors of use of complementary and alternative therapies among patients with cancer. Oncol Nurs Forum. 2005;32(6):1115-1122. doi:10.1188/05.ONF.1115-1122.
44. Greenlee H, Kwan ML, Egras IJ, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009;117(3):653-655.
45. Miller M, Boyer MJ, Butow PN, Gattellari M, Dunn SM, Childs A. The use of unproven methods of treatment by cancer patients:Frequency, expectations and cost Support Care Cancer. 1998;6(4):337-347.
46. Salmenpera L. The use of complementary therapies among breast and prostate cancer patients in Finland. Eur J Cancer Care. 2002;11(1):44-50.
47. Sewitch MJ, Rajput Y. A literature review of complementary and alternative medicine use by colorectal cancer patients. Complement Ther Clin Pract. 2010;16(1):52-56.
48. Sparber A, Wootton JC. Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies. J Altern Complement Med. 2001;7(3):281-287.
49. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther. 2005;4(4):274-286.
50. Wanchai A, Armer JM, Stewart BR. Complementary and alternative medicine use among women with breast cancer: A systematic review. Clin J Oncol Nurs. 2010;14(4):E45-E55.
51. Yates JS, Mustian KM, Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13(10):806-811.
52. World Health Organization. Definition of palliative care. Geneva, Switzerland: World Health Organization; 2012.
53. Higginson IJ, Costanini M. Dying with cancer, living well with advanced cancer. Eur J Cancer. 2008;44(10):1414-1424.
54. McClement SE, Chochinov HM. Hope in advanced cancer patients. Eur J Cancer. 2008;44(8):1169-1174.
55. Boon H, Westlake K, Stewart M, et al. Use of complementary/ alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology. 2003;62(5):849-853.
56. Er O, Mistik S, Ozkan M, Ozturk A, Altinbas M. Factors related to complementary/alternative medicine use among cancer patients in central Anatolia. Tumori. 2008;94(6):833-837.
57. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92(1):42-47.
58. Nagel G, Hoyer H, Katenkamp D. Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey. Support Care Cancer. 2004;12(11):789-796.
59. National Center for Complementary and Alternative Medicine. What is CAM? nccam.nih.gov. 2007. Available at: http://nccam. nih.gov/health/whatiscam/. Accessed March 1, 2008.
60. Pluye P, Gagnon MP, Griffiths F, Johnson-Lafleur J. A scoring system for appraising mixed methods research, and concomitantly appraising qualitative, quantitative, and mixed methods primary studies in Mixed Studies Review. Int J Nurs Stud. 2009;46(4):529-546.
61. National Institutes of Health. Medical subject headings. 2013. Available at: www.nlm.nih.gov/mesh. Accessed February 14 2012.
62. Cook AM, Finlay AG, Edwards AG, et al. Efficiency of searching the grey literature in palliative care. J Pain Symptom Manage. 2001;22(3):797-801.
63. MacDonald SM, Harris EE, Arthur DW, et al. ACR Appropriateness criteria® locally advanced breast cancer. Breast J. 2011;17(6):579-585.
64. WHO Regional Office for Europe. European observatory on health systems and policies. euro.who.int. 2013. Available at: http:// www.euro.who.int/en/who-we-are/partners/observatory/healthsystems- in-transition-hit-series. Accessed September 15 2012.
65. Moher D, Liberati A, Tetzlaff J, Altman DG; Prisma Group. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement. Int J Surg. 2010;8(5):336-341.
66. Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. Results of an ESRC funded research project. Lancaster, UK: Institute for Health Research, Lancaster University; 2006:92.
67. Beadle GF, Yates PM, Najman JM, et al. Beliefs and practices of patients with advanced cancer: implications for communication. Br J Cancer. 2004;91(2):254-257.
68. Bishop FL, Yardley L. Constructing agency in treatment decisions:negotiating responsibility in cancer. Health. 2004;84(4):465-482.
69. Mirabeau-Beale KL, Kornblith AB, Penson RT, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009;114(2):353-359.
70. Gözüm S, Tezel A, Koc M. Complementary alternative treatments used by patients with cancer in eastern Turkey. Cancer Nurs. 2003;26(3):230-236.
71. Beadle GF, Yates PM, Najman JM, et al. Illusions in advanced cancer: the effect of belief systems and attitudes on quality of life. Psychooncology. 2004;13(1):26-36.
72. Smithson J, Britten N, Paterson C, Lewith G, Evans M. The experience of using complementary therapies after a diagnosis of cancer: A qualitative synthesis. Health (London). 2010;16(1):19-39.
73. Mao JJ, Cronholm PF, Stein E, Straton JB, Palmer SC, Barg FK. Positive changes, increased spiritual importance, and complementary and alternative medicine (CAM) use among cancer survivors. Integr Cancer Ther. 2010;9(4):339-347.
74. Söllner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer. 2000;89(4):873-880.
75. Dunwoody L, Smyth A, Davidson R. Cancer patients' experiences and evaluations of aromatherapy massage in palliative care. Int J Palliat Nurs. 2002;8(10):497-504.
76. Balneaves LG, Truant TL, Kelly M, Verhoef MJ, Davison BJ. Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM). Support Care Cancer. 2007;15(8):973-983.
77. Balneaves LG, Weeks L, Seely D. Patient decision-making about complementary and alternative medicine in cancer management:context and process. Curr Oncology. 2008;15(Suppl 2):s24-s100.
78. Truant TL, Bottorff JL. Decision making related to complementary therapies: a process of regaining control. Patient Educ Couns. 1999;38(2):131-142.
79. Ben-Ayre B, Visser A. The role of health care communication in the development of complementary and integrative medicine. Patient Educ Couns. 2012;89(3):363-367.
80. Davis EL, Oh B, Butow PN, Mullan BA, Clarke S. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist. 2012;17(11):1475-1481.
81. Evans M, Sharp D, Shaw A. Developing a model of decisionmaking about complementary therapy use for patients with cancer:a qualitative study. Patient Educ Couns. 2012;89(3):374-380.
82. Frenkel M, Ben-Arye E, Cohen L. Communication in cancer care:discussing complementary and alternative medicine. Integr Cancer Ther. 2010;9(2):177-185.
83. Oh B, Butow P, Mullan B, et al. Patient-doctor communication:use of complementary and alternative medicine by adult patients with cancer. J Soc Integr Oncol. 2010;8(2):56-64.
84. Popper-Giveon A, Schiff E, Ben-Ayre E. I will always be with you:traditional and complementary therapists' perspectives on patienttherapist- doctor communication regarding treatment of Arab patients with cancer in Israel. Patient Educ Couns. 2012;89(3):381-386.
85. Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M. Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns. 2010;79(2):143-151.
86. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology. 2002;11(3):212-220.
87. Zhang Y, Peck K, Spalding M, Jones B, Cook RL. Discrepancy between patients' use of and health providers' familiarity with CAM. Patient Educ Couns. 2012;89(3):399-404.
88. Wilkinson S, Gomella LG, Smith JA, et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol. 2002;168(6):2505-2509.
89. Taylor SE, Brown JD. Illusion and well-being: a social psychological perspective on mental health. Psychol Bull. 1988;103(2):193-210.
90. Innes S, Payne S. Advanced cancer patients' prognostic information preferences: a review. Palliat Med. 2008;23(1):29-39.
91. Lin HR, Bauer-Wu SM. Psycho-spiritual well-being in patients with advanced cancer: an integrative review of the literature. J Adv Nurs. 2003;44(1):69-80.
92. Arthur K, Belliard JC, Hardin SB, Knecht K, Chen CS, Montgomery S. Practices, attitudes, and beliefs associated with complemetnary and alternative medicine (CAM) use among cancer patients. Integr Cancer Ther. 2012;11(3):232-242.
93. Johnson S. Hope in terminal illness: an evolutionary concept analysis. J Palliat Nurs. 2007;13(9):451-459.
94. Deng G, Frenkel M, Cohen L, et al; Society for Integrative Oncology. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7(3):85-120.
95. Ajzuddin, Saraf S. Legal regulations of complementary and alternative medicines in difference countries. Pharmacogn Rev. 2012;6(12):154-160.
96. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 2004;12(6):454-462.